Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2016

01-02-2016 | Original Article

Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland

Authors: M. James, C. Goodchild, S. Bashir, M. Mannix

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2016

Login to get access

Abstract

Background

With concerns that blind registration in Ireland due to diabetic retinopathy is continuing to rise, a structured retinopathy screening service is in the process of being rolled out nationally.

Aims

To report on the validation process for creating a register of diabetics in the Mid-West of Ireland, and findings following retinopathy screening of a representative sample.

Methods

National primary care databases were employed in generating provisional lists of diabetic patients in the Health Service Executive (HSE) Mid-West area. Subsequent engagement with the corresponding general practices over a three year period between 2010 and 2013 facilitated the validation of these lists. A summary of the retinopathy screening outcomes of 1,434 patients and pre-existing screening patterns is reported.

Results

The number of patients on the Mid-West diabetes register to date is 11,126. Of the 1,434 patients screened, 288 (20.1 %) had background retinopathy, while 117 (8.2 %) had sight-threatening retinopathy. Seventeen (19.8 %) of the 86 patients identified with maculopathy required treatment with intravitreal injections. Of the 610 patients questioned about previous screening events, 389 (63.8 %) said they had undergone an ocular examination within the previous 12 months.

Conclusions

The HSE Mid-West has over 11,000 patients on its database ready to be screened by the national programme, with the treatment of maculopathy expected to have the largest impact on resources. Although the majority of patients are already undergoing screening in the community in an ad hoc fashion, the rates of sight-threatening retinopathy encountered highlight the timeliness of the full implementation of the national programme.
Literature
1.
go back to reference International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. International Diabetes Federation, Brussels International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. International Diabetes Federation, Brussels
3.
go back to reference Kelliher C, Kenny D, O’ Brien C (2006) Trends in blind registration in the adult population of the Republic of Ireland 1996–2003. Br J Ophthalmol 90:367–371PubMedPubMedCentralCrossRef Kelliher C, Kenny D, O’ Brien C (2006) Trends in blind registration in the adult population of the Republic of Ireland 1996–2003. Br J Ophthalmol 90:367–371PubMedPubMedCentralCrossRef
4.
go back to reference National Council for the Blind of Ireland (2011) The cost of sight loss: the economic impact of vision impairment and blindness in the Republic of Ireland. NCBI Publications, Dublin National Council for the Blind of Ireland (2011) The cost of sight loss: the economic impact of vision impairment and blindness in the Republic of Ireland. NCBI Publications, Dublin
5.
go back to reference Bachmann MO, Nelson SJ (1998) Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 52:45–52PubMedPubMedCentralCrossRef Bachmann MO, Nelson SJ (1998) Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 52:45–52PubMedPubMedCentralCrossRef
6.
go back to reference Balanda KP, Barron S, Fahy L (2010) Making chronic conditions count: hypertension, coronary heart disease, stroke, diabetes. A systematic approach to estimating and forecasting population prevalence on the island of Ireland. Executive summary. Institute of Public Health in Ireland, Dublin Balanda KP, Barron S, Fahy L (2010) Making chronic conditions count: hypertension, coronary heart disease, stroke, diabetes. A systematic approach to estimating and forecasting population prevalence on the island of Ireland. Executive summary. Institute of Public Health in Ireland, Dublin
7.
go back to reference Delcourt C, Massin P, Rosilio M (2009) Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population. Diabet metab 35:431–438CrossRef Delcourt C, Massin P, Rosilio M (2009) Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population. Diabet metab 35:431–438CrossRef
8.
go back to reference Health Service Executive Expert Advisory Group National Retinopathy Screening Committee (2008) Framework for the development of a diabetic retinopathy screening programme for Ireland. Health Service Executive, Kildare Health Service Executive Expert Advisory Group National Retinopathy Screening Committee (2008) Framework for the development of a diabetic retinopathy screening programme for Ireland. Health Service Executive, Kildare
9.
go back to reference Harding S, Greenwood R, Aldington S et al (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 20:965–971PubMedCrossRef Harding S, Greenwood R, Aldington S et al (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 20:965–971PubMedCrossRef
10.
go back to reference Cooke M, Leane G, Mannix M et al (2010) Development of a diabetes register in Ireland: feasibility study—recommendations for the establishment of a register. Health Service Executive, Kildare Cooke M, Leane G, Mannix M et al (2010) Development of a diabetes register in Ireland: feasibility study—recommendations for the establishment of a register. Health Service Executive, Kildare
11.
go back to reference Williams R, Airey M, Baxter H et al (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18:963–983PubMedCrossRef Williams R, Airey M, Baxter H et al (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18:963–983PubMedCrossRef
12.
go back to reference Mc Hugh S, Buckley C, Murphy K et al (2013) Quality-assured screening for diabetic retinopathy delivered in primary care in Ireland: an observational study. Br J Gen Pract 63:85–86CrossRef Mc Hugh S, Buckley C, Murphy K et al (2013) Quality-assured screening for diabetic retinopathy delivered in primary care in Ireland: an observational study. Br J Gen Pract 63:85–86CrossRef
13.
go back to reference Younis N, Broadbent DM, Harding SP et al (2002) Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 19:1014–1021PubMedCrossRef Younis N, Broadbent DM, Harding SP et al (2002) Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 19:1014–1021PubMedCrossRef
14.
go back to reference Broadbent DM, Scott JA, Vora JP et al (1999) Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 13:160–165PubMedCrossRef Broadbent DM, Scott JA, Vora JP et al (1999) Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 13:160–165PubMedCrossRef
15.
go back to reference Raymond NT, Varadhan L, Reynold DR et al (2009) Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 32:410–415PubMedPubMedCentralCrossRef Raymond NT, Varadhan L, Reynold DR et al (2009) Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 32:410–415PubMedPubMedCentralCrossRef
16.
go back to reference Forster AS, Forbes A, Dodhia H et al (2013) Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care 36:2663–2669PubMedPubMedCentralCrossRef Forster AS, Forbes A, Dodhia H et al (2013) Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care 36:2663–2669PubMedPubMedCentralCrossRef
17.
go back to reference Looker HC, Nyangoma SO, Cromie DT et al (2014) Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol 98:790–795PubMedPubMedCentralCrossRef Looker HC, Nyangoma SO, Cromie DT et al (2014) Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol 98:790–795PubMedPubMedCentralCrossRef
18.
go back to reference Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615–625PubMedCrossRef Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615–625PubMedCrossRef
19.
go back to reference Scanlon PH, Carter S, Foy C et al (2005) An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme. Br J Ophthalmol 89:971–975PubMedPubMedCentralCrossRef Scanlon PH, Carter S, Foy C et al (2005) An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme. Br J Ophthalmol 89:971–975PubMedPubMedCentralCrossRef
20.
go back to reference Cugati S, Kifley A, Mitchell P et al (2006) Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract 74:301–308PubMedCrossRef Cugati S, Kifley A, Mitchell P et al (2006) Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract 74:301–308PubMedCrossRef
21.
go back to reference Leese GP, Morris AD, Swaminathan K et al (2005) Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 22:1112–1115PubMedCrossRef Leese GP, Morris AD, Swaminathan K et al (2005) Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 22:1112–1115PubMedCrossRef
22.
go back to reference James M, Heng TH, Minasyan D (2014) A quantitative analysis of diabetic retinopathy screening in a regional treatment centre. Ir Med J 107:321–323PubMed James M, Heng TH, Minasyan D (2014) A quantitative analysis of diabetic retinopathy screening in a regional treatment centre. Ir Med J 107:321–323PubMed
23.
go back to reference Javitt JC, Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124:164–169PubMedCrossRef Javitt JC, Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124:164–169PubMedCrossRef
24.
25.
go back to reference Schoenfeld ER, Greene JM, Wu SY et al (2001) Patterns of adherence to diabetes vision care guidelines: baseline findings from the diabetic retinopathy awareness program. Ophthalmol 108:563–571CrossRef Schoenfeld ER, Greene JM, Wu SY et al (2001) Patterns of adherence to diabetes vision care guidelines: baseline findings from the diabetic retinopathy awareness program. Ophthalmol 108:563–571CrossRef
26.
go back to reference MacLellan PA, McGwin G, Heckemeyer C et al (2014) Eye care use among a high-risk diabetic population seen in a public hospital’s clinics. JAMA Ophthalmol 132:162–167CrossRef MacLellan PA, McGwin G, Heckemeyer C et al (2014) Eye care use among a high-risk diabetic population seen in a public hospital’s clinics. JAMA Ophthalmol 132:162–167CrossRef
27.
go back to reference Mukamel DB, Bresnick GH, Wang Q et al (1999) Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 6:61–72PubMedCrossRef Mukamel DB, Bresnick GH, Wang Q et al (1999) Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 6:61–72PubMedCrossRef
28.
go back to reference Chalk D, Pitt M, Vaidya B et al (2012) Can the retinal screening interval be safely increased to 2 years for Type 2 diabetic patients without retinopathy? Diabetes Care 35:1663–1668PubMedPubMedCentralCrossRef Chalk D, Pitt M, Vaidya B et al (2012) Can the retinal screening interval be safely increased to 2 years for Type 2 diabetic patients without retinopathy? Diabetes Care 35:1663–1668PubMedPubMedCentralCrossRef
29.
go back to reference Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedPubMedCentralCrossRef Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedPubMedCentralCrossRef
30.
go back to reference Bagga P, Verma D, Walton C et al (1998) Survey of diabetic retinopathy screening services in England and Wales. Diabet Med 15:780–782PubMedCrossRef Bagga P, Verma D, Walton C et al (1998) Survey of diabetic retinopathy screening services in England and Wales. Diabet Med 15:780–782PubMedCrossRef
31.
go back to reference Dervan E, Lillis D, Flynn L et al (2008) The factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177:303–308PubMedCrossRef Dervan E, Lillis D, Flynn L et al (2008) The factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177:303–308PubMedCrossRef
32.
go back to reference Hutchinson A, McIntosh A, Peters J et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy—a systematic review. Diabet Med 17:495–506PubMedCrossRef Hutchinson A, McIntosh A, Peters J et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy—a systematic review. Diabet Med 17:495–506PubMedCrossRef
33.
go back to reference James M, Turner DA, Broadbent DM et al (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J 320:1627–1631CrossRef James M, Turner DA, Broadbent DM et al (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J 320:1627–1631CrossRef
34.
go back to reference Harwell TS, Moore K, Madison M et al (2001) Comparing self-reported measures of diabetes care with similar measures from a chart audit in a well-defined population. Am J Med Qual 16:3–8PubMedCrossRef Harwell TS, Moore K, Madison M et al (2001) Comparing self-reported measures of diabetes care with similar measures from a chart audit in a well-defined population. Am J Med Qual 16:3–8PubMedCrossRef
Metadata
Title
Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland
Authors
M. James
C. Goodchild
S. Bashir
M. Mannix
Publication date
01-02-2016
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2016
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-015-1248-y

Other articles of this Issue 1/2016

Irish Journal of Medical Science (1971 -) 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine